These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7805358)

  • 1. Bacteriologic characteristics and antimicrobial susceptibility of 70 clinically significant isolates of Streptococcus milleri group.
    Gómez-Garcés JL; Alós JI; Cogollos R
    Diagn Microbiol Infect Dis; 1994 Jun; 19(2):69-73. PubMed ID: 7805358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro antimicrobial susceptibility of the "Streptococcus milleri' group (Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius).
    Jacobs JA; Stobberingh EE
    J Antimicrob Chemother; 1996 Feb; 37(2):371-5. PubMed ID: 8707750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year analysis of antimicrobial susceptibility of the Streptococcus milleri group.
    Limia A; Jiménez ML; Alarcón T; López-Brea M
    Eur J Clin Microbiol Infect Dis; 1999 Jun; 18(6):440-4. PubMed ID: 10442424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of some streptococci strains of anginosus group isolated from oral and maxillofacial infections.
    Băncescu G; Skaug N; Dumitriu S; Băncescu A
    Roum Arch Microbiol Immunol; 1999; 58(1):57-63. PubMed ID: 11845446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(1):10-20. PubMed ID: 8996736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States.
    Doern GV; Ferraro MJ; Brueggemann AB; Ruoff KL
    Antimicrob Agents Chemother; 1996 Apr; 40(4):891-4. PubMed ID: 8849246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Susceptibility to penicillin and 13 antimicrobial agents in erythromycin-resistant viridans group streptococci isolated from blood cultures].
    Rodríguez-Avial C; Rodríguez-Avial I; Picazo JJ
    Rev Esp Quimioter; 2001 Sep; 14(3):275-80. PubMed ID: 11753449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Problems with identification of beta-hemolytic streptococcus resistant to bacitracin isolated from patients with pharyngitis].
    Olender A; Łetowska I; Karyński M; Kiernicka-Ciekot K; Pels K
    Med Dosw Mikrobiol; 2012; 64(1):1-10. PubMed ID: 22808724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis.
    Teng LJ; Hsueh PR; Chen YC; Ho SW; Luh KT
    J Antimicrob Chemother; 1998 Jun; 41(6):621-7. PubMed ID: 9687100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures.
    Potgieter E; Carmichael M; Koornhof HJ; Chalkley LJ
    Eur J Clin Microbiol Infect Dis; 1992 Jun; 11(6):543-6. PubMed ID: 1526239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of sixty-five non-oral clinical isolates of the Streptococcus milleri group to seven antimicrobial agents.
    Horton WA; Drucker DB; Jacob AE; Hillier VF
    Microbios; 1992; 71(287):125-34. PubMed ID: 1453983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic susceptibility of alpha- and nonhemolytic streptococci from patients and healthy adults to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(2):123-31. PubMed ID: 9084921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral streptococcal strains isolated from odontogenic infections and their susceptibility to antibiotics.
    Bancescu G; Dumitriu S; Bancescu A; Pana M; Andrei M
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):1012-5. PubMed ID: 17438917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotic resistance analysis of
    Ge LL; Han ZY; Liu AH; Zhu L; Meng JH
    Zhonghua Er Ke Za Zhi; 2017 Feb; 55(2):109-114. PubMed ID: 28173648
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains.
    Tracy M; Wanahita A; Shuhatovich Y; Goldsmith EA; Clarridge JE; Musher DM
    Antimicrob Agents Chemother; 2001 May; 45(5):1511-4. PubMed ID: 11302819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species belonging to the "Streptococcus milleri" group: antimicrobial susceptibility and comparative prevalence in significant clinical specimens.
    Bantar C; Fernandez Canigia L; Relloso S; Lanza A; Bianchini H; Smayevsky J
    J Clin Microbiol; 1996 Aug; 34(8):2020-2. PubMed ID: 8818904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of 278 streptococcal blood isolates to seven antimicrobial agents.
    Renneberg J; Niemann LL; Gutschik E
    J Antimicrob Chemother; 1997 Feb; 39(2):135-40. PubMed ID: 9069532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Streptococcus milleri" endocarditis caused by Streptococcus anginosus.
    Woo PC; Tse H; Chan KM; Lau SK; Fung AM; Yip KT; Tam DM; Ng KH; Que TL; Yuen KY
    Diagn Microbiol Infect Dis; 2004 Feb; 48(2):81-8. PubMed ID: 14972375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptococcus milleri group: renewed interest in an elusive pathogen.
    Piscitelli SC; Shwed J; Schreckenberger P; Danziger LH
    Eur J Clin Microbiol Infect Dis; 1992 Jun; 11(6):491-8. PubMed ID: 1526231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.